The Vaccine had earlier this month gone into Human testing phase and BBC news and Aljazeera now report that the results of the testing on Humans has been 'Very Positive'.
The Vaccine called, AZD1222 after being applied showed a very healthy immune boost in patients and in almost all cases it showed that it produced a dual immune response in people between ages 18-55. There has also been no side effects noticed and the immunity created has lasted 2 months for those immunized.
Human Trials Commence
This is extremely, great news, however Dr Adrian Hill of the Jenner Institute at Oxford has warned that it is not exactly over yet until the vaccine is tested more widely and in other parts of the world. Testing has already begun in South Africa And Brazil and will spread to the US in a few weeks.
Dr Adrian Hill
Let us all pray that is is what we have all been waiting for, the end of this pandemic, once and for all!!
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform